After Monsanto reported stronger than expected Q3 results and reiterated its fiscal 2015 EPS guidance, BMO Capital says that the stock's decline was due to the company's bearish comments on the short-term outlook for foreign exchange, crop prices, and acreage. The firm thinks that the stock will probably be range bound until its bid for Syngenta is resolved, but it thinks that Monsanto's stock is inexpensive. However, BMO warns that the company's targets could be at risk if it fails to acquire Syngenta. The firm lowered its price target on Monsanto to $127 from $132 but keeps an Outperform rating on the shares.